Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial

RC Hermida, DE Ayala, A Mojón, JR Fernández - Diabetologia, 2016 - Springer
Aims/hypothesis We investigated whether therapy with the entire daily dose of≥ 1
hypertension medications at bedtime exerts greater reduction in the risk of new-onset …

Influence of time of day of blood pressure–lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes

RC Hermida, DE Ayala, A Mojón… - Diabetes care, 2011 - Am Diabetes Assoc
OBJECTIVE We prospectively investigated in hypertensive patients with type 2 diabetes if
bedtime treatment with≥ 1 hypertension medications exerts better blood pressure control …

Risk of incident chronic kidney disease is better reduced by bedtime than upon-awakening ingestion of hypertension medications

RC Hermida, DE Ayala, A Mojon… - Hypertension Research, 2018 - nature.com
This trial investigated whether therapy with the entire daily dose of≥ 1 hypertension
medications at bedtime exerts a greater reduction in the risk of incident chronic kidney …

Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes

A Moya, JJ Crespo, DE Ayala, MT Rios… - Chronobiology …, 2013 - Taylor & Francis
Generally, hypertensive patients ingest all their blood pressure (BP)-lowering agents in the
morning. However, many published prospective trials have reported clinically meaningful …

Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial

RC Hermida, JJ Crespo… - European heart …, 2020 - academic.oup.com
Abstract Aims The Hygia Chronotherapy Trial, conducted within the clinical primary care
setting, was designed to test whether bedtime in comparison to usual upon awakening …

Does timing of antihypertensive medication dosing matter?

RC Hermida, RG Hermida-Ayala… - Current Cardiology …, 2020 - Springer
Abstract Purpose of Review Current hypertension guidelines do not provide
recommendation on when-to-treat. Herein, we review the current evidence on ingestion-time …

Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications

RC Hermida, DE Ayala, A Mojon… - Chronobiology …, 2013 - Taylor & Francis
A number of observational studies have found that treated hypertensive patients, even those
with controlled clinic blood pressure (BP), might have poorer prognosis than untreated …

Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease

JJ Crespo, L Piñeiro, A Otero, C Castiñeira… - Chronobiology …, 2013 - Taylor & Francis
Many published prospective trials have reported clinically meaningful morning-evening,
treatment-time differences in the blood pressure (BP)-lowering efficacy, duration of action …

Extent of asleep blood pressure reduction by hypertension medications is ingestion-time dependent: Systematic review and meta-analysis of published human trials

RC Hermida, A Mojon, RG Hermida-Ayala… - Sleep Medicine …, 2021 - Elsevier
Combined evidence of published prospective outcome trials and meta-analyses
substantiate elevated asleep blood pressure (BP) and blunted sleep-time relative BP …

[HTML][HTML] Ingestion-time differences in the pharmacodynamics of hypertension medications: Systematic review of human chronopharmacology trials

RC Hermida, RG Hermida-Ayala… - Advanced Drug Delivery …, 2021 - Elsevier
Pharmacokinetics of hypertension medications is significantly affected by circadian rhythms
that influence absorption, distribution, metabolism and elimination. Furthermore, their …